Johanna Friedl-Naderer, Chief Officer of Dyne Therapeutics DYN, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $12K. The latest trade was on 06/16.

JF

JF

Johanna Friedl-Naderer

Chief Commercial Officer

Company

Dyne Therapeutics DYN

First filing

23/02/24

Trades

18 trades

Buys / sales

0 / 9

12-month net buying

−$12K

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	06/16	06/17	145 sh	$18.33	$2,657.85	−0.1%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	05/13	05/14	228 sh	$18.36	$4,186.08	−0.1%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	03/05	03/06	148 sh	$14.90	$2,205.2	−0.1%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/12/05	25/12/05	144 sh	$20.72	$2,983.68	−0.2%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/09/04–25/09/05	25/09/08	1,038 sh2 trades	$13.29avg.	$13,794.42	−1.1%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/06/05	25/06/06	146 sh	$13.35	$1,949.1	−0.2%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/03/13	25/03/13	143 sh	$12.12	$1,733.16	−0.1%
Vir BiotechnologyVIR	Open-market sale	23/03/03	23/03/07	1,482 sh	$22.82	$33,819.24	−1.0%